Mycenax Biotech (4726) — Working Capital to Net Assets Ratio
Mycenax Biotech (4726) has a Working Capital to Net Assets ratio of -16.8% as of September 2025. Working capital of NT$-275.15 Million (current assets of NT$804.75 Million minus current liabilities of NT$1.08 Billion) is measured against net assets of NT$1.64 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Mycenax Biotech balance sheet quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Mycenax Biotech Working Capital to Net Assets (2017–2024)
This chart shows how Mycenax Biotech's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at -16.8%, reflecting working capital of NT$-275.15 Million against net assets of NT$1.64 Billion TWD. Check Mycenax Biotech (4726) tangible net worth to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Mycenax Biotech (2017–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Mycenax Biotech from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Mycenax Biotech.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 3.7% | NT$74.89 Million | NT$2.02 Billion | NT$736.38 Million | NT$661.50 Million | ▼ -10.4 pp |
| 2023 | 14.1% | NT$344.59 Million | NT$2.45 Billion | NT$1.10 Billion | NT$753.42 Million | ▼ -27.4 pp |
| 2022 | 41.5% | NT$1.29 Billion | NT$3.11 Billion | NT$1.92 Billion | NT$634.73 Million | ▲ +22.8 pp |
| 2021 | 18.7% | NT$357.34 Million | NT$1.91 Billion | NT$897.41 Million | NT$540.07 Million | ▲ +6.2 pp |
| 2020 | 12.5% | NT$151.73 Million | NT$1.21 Billion | NT$576.51 Million | NT$424.78 Million | ▼ -11.3 pp |
| 2019 | 23.9% | NT$263.04 Million | NT$1.10 Billion | NT$494.96 Million | NT$231.91 Million | ▼ -7.6 pp |
| 2018 | 31.5% | NT$285.49 Million | NT$907.01 Million | NT$465.54 Million | NT$180.05 Million | ▼ -24.3 pp |
| 2017 | 55.8% | NT$637.91 Million | NT$1.14 Billion | NT$765.69 Million | NT$127.78 Million | — |